Total submissions: 5
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV000875362 | SCV001017676 | likely benign | Nemaline myopathy 2 | 2024-07-17 | criteria provided, single submitter | clinical testing | |
Mayo Clinic Laboratories, |
RCV001508089 | SCV001714010 | uncertain significance | not provided | 2020-11-02 | criteria provided, single submitter | clinical testing | |
Revvity Omics, |
RCV001508089 | SCV003811614 | likely benign | not provided | 2023-04-12 | criteria provided, single submitter | clinical testing | |
Gene |
RCV001508089 | SCV004169156 | uncertain significance | not provided | 2023-05-11 | criteria provided, single submitter | clinical testing | In silico analysis supports that this missense variant does not alter protein structure/function; Has not been previously published in association with NEB-related nemaline myopathy to our knowledge; This variant is associated with the following publications: (PMID: 28719003, 26740555) |
Natera, |
RCV000875362 | SCV001457001 | uncertain significance | Nemaline myopathy 2 | 2020-01-10 | no assertion criteria provided | clinical testing |